Felix Agbo

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

Edward A. Sausville, Patricia LoRusso, Michael A. Carducci et al. · Cancer Chemotherapy and Pharmacology · 2014 · 195 citations · Full text

Checkpoint Kinase Inhibitor, Medicine, Pathology +7

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours

Takashi Seto, Taito Esaki, Fumihiko Hirai et al. · Cancer Chemotherapy and Pharmacology · 2013 · 101 citations

Dose-escalation Study, Radiation Medicine, Medicine +10

Pharmacokinetics and Pharmacodynamics of Anastrozole in Pubertal Boys with Recent-Onset Gynecomastia

Nelly Mauras, Kim Bishop, Debbie Merinbaum et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 52 citations

Phase I, open-label, dose-escalation study of AZD7762 in combination with irinotecan (irino) in patients (pts) with advanced solid tumors.

Alan L. Ho, J. C. Bendell, J. M. Cleary et al. · Journal of Clinical Oncology · 2011 · 33 citations

Xenograft Models, Pathology, Pharmacotherapy +19

Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study

Felix Agbo, Stuart Isaacson, Ramon Gil et al. · Neurology and Therapy · 2021 · 26 citations · Full text